Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
Join the club for FREE to access the whole archive and other member benefits.
Contributing editor to Longevity Technology
Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Details last updated 10-Feb-2020
A next-gen retinal implant offers new hope for vision loss from macular degeneration
It avoids common delivery problems and enters Phase 1 trials in 2025
Scandinavian biotech targets fibrosis with novel scar-blocking therapies
It uses blood tests to find early health risks and gives personalised advice
Clinical trials are beginning, backed by major investors like Novo Holdings
Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
naturalX backs startups reshaping wellness and prevention
The Dutch startup is using ion channel research and advanced tech to develop new treatments
Backed by AI and genetics, Junevity targets age-related diseases
Cutting-edge DNA analysis provides affordable, real-time health insights
Full-body scans drive early detection as Neko expands globally
Early trials show reduced stroke risks and slower progression
Company aims to predict diseases, design therapies, and revolutionise research
It holds potential for treating inflammation, cancer, ageing, and autoimmunity
Dual-action therapies tackling inflammation, metabolism, and neurodegeneration
The company has raised $16 million from investors
Clinical trials have begun on patients with severe kidney disease
This breakthrough combines large biological datasets and advanced AI tools
Biotech firm advances osteoporosis therapies and strengthens leadership with key appointment
Focus areas include gene editing, stem cell therapies, and affordable health solutions
The treatment "JOTROL" shows promise in cognitive and brain health conditions
Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis
Powered by AI, pocdoc accelerates early detection and treatment of chronic diseases
Breakthrough MOTYS moves to phase 3 trials, promising lasting relief for knee osteoarthritis
Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking
Initial focus on lowering cholesterol by targeting NAD+ metabolism
Funding strengthens their capacity to address unmet needs in immune-related diseases
Initiatives like The Human Phenotype project aim to improve disease diagnostics and predictions
New funding powers AI-driven implants to revolutionize neurological care
Aliada’s BBB technology aims to transform CNS drug delivery
They aim to use AI-driven capsid design for delivery for complex treatments
Their partnership with Calico focuses on age-related disease treatments
They use stem cell technology to regenerate the thymus and aim to slow its natural decline
Shift aims to treat diseases like heart issues and arthritis by addressing aging’s root causes
New proteasome-activating drugs aim to tackle neurodegenerative diseases and extend healthy lifespan
Targeted cell depletion offers a transformative strategy to treat diseases at their root
Clock.bio secures funding to explore genetic pathways for enhancing healthspan
The startup leverages its TFome™ platform for rapid and efficient iPSC programming
An AI model set to transform drug discovery through cutting-edge molecular predictions
Boosting fat loss and preserving muscle with cutting-edge mitochondrial therapy
German startup decodes the dark genome, advancing precision medicine
Transforming healthcare with non-invasive, drug-free technology
Funding will primarily be used to advance therapies focused on muscle growth
Funding fuels clinical trials of a lead compound, offering hope for liver disease patients
Company is particularly focusing on less invasive treatments for dry AMD and XLRP
This could eventually lead to new ways to prevent and treat age-related diseases
Public support can play a crucial role in accelerating progress
Canadian company secures $8M to unlock future regenerative therapies through cryopreservation
The company aims to expand access to this technology for broader healthcare impact
Company aims to improve protein production in genetic medicine
Company is developing therapies for Alzheimer's, Parkinson's, and Rett syndrome
Company's approach involves detecting, correcting, and eliminating damaged cells
This technology could potentially improve the quality of life for many older individuals
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions
Company is aiming to increase accessibility and affordability
Their test, MyPhenome, identifies different types of obesity to tailor treatment plans
Promises faster development and wider access of cell therapies for age-related diseases
Technology aims to make animal studies more efficient, affordable, and humane
AI-powered platform predicts drugs for age-related diseases with 80% accuracy
AI-powered protein design models to transform medicine with next-gen therapeutics
Potentially leading to breakthroughs in managing chronic diseases
Longevity AI app offers personalized guidance based on exercise, diet, and sleep data
Technology promises faster identification of molecules for disease treatment
Funding fuels R&D, and collaboration focus on improving diagnosis and treatment options
This investment supports the development of innovative pill-based therapies that use healthy gut bacteria
Company will use machine learning and gut health science to create custom solutions
Company aims to revolutionize preventative healthcare using health tracking system
Company's innovative "liquid cornea" technology shows promise in restoring vision
iPSC-based therapy set for phase 1 trials to replace lost neurons and modify disease course
Investment fuels its blood-brain barrier-crossing tech for better drug delivery
This powerful AI could transform how we approach disease research
They plan to offer quick full-body scans for $500 in a few years
Their treatment uses implanted cells to calm brain activity and repair damaged networks
Early studies look promising, and the company plans to launch its product soon
They picked RJVA-001, a gene therapy, as their first clinical candidate
Company aims to shift medicine's focus from illness treatment to proactive health optimization
Vesper's main drug, called VES001, is a pill that can reach the brain directly
Shown promising results in preclinical studies and early clinical trials
This, they claim, is safer and more precise than traditional gene editing methods
Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Silicon Valley startup uses personalized data and AI twin to reverse type 2 diabetes and obesity
Company's drug targets the root cause of diseases like Duchenne and COPD
AI-powered data platform empowers early disease detection and proactive care at home
The drugs target obesity, diabetes, and potentially, human longevity
Offers over 20 innovative organ models for realistic testing and collaborating
Company's pipeline targets inflammation, promote healing, and restore quality of life
Company's fasting mimicking technology could revolutionise ageing
Company's "cell-free DNA platform" can detect unexplored cell-free DNA fragments
Company aims to impact a billion people's lives in five years
Aims for Alzheimer's drugs that target brain's predominant cells, astrocytes
Technology could revolutionise the treatment of degenerative diseases
A single dose of mRNA therapy could rewind ageing and extend lifespan
Pig plasma therapy could reverse aging in humans
Novel approach to identify ageing targets and fight age-related diseases
Details magic of converting stem cells to any cell type and transplanting them to treat age-related conditions
VitalOne reports 50 lab tests in just 20 minutes and improves accessibility for clinicians & patients
Ground-breaking technology to advance the development of a bio-engineered thymus & lung disease treatments
Aims to extend human healthspan and promote impactful lifestyle changes
AI-powered insights to help doctors prevent disease and boost healthspan
Longevity Technology interviews CEO Melanie Goldey
The researchers will not only focus on CVD or cellular aging but the optimal point of intervention
Had success in reducing muscle atrophy and discovered novel class of molecules to target cognitive decline
Likely to be discussions before stock is removed from sale - and should still be available in the UK
Detecting disease at the earliest stages and reversing it, instead of treating a chronic disease
Cells are already in the right place, just need the right kick to help repair the body when needed
If successful in humans it would improve the outcome of many age-related diseases
Looks like it will act as an interface between longevity researchers and clinicians
Camera on each petri dish captures healthspan of many worms simultaneously
Eliminating senescent cells rejuvenates the heart's capacity for regeneration in mice
Vitalunga to usher the novel drug for hepatocellular carcinoma clinical trials
Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic
Different flavours of rapalogs targeting different age-related conditions
Maybe a longevity drug within 5 years, but still lots more research needed into process of ageing
How emerging science and lifestyle choices could extend life and transform society
Funding will ensure the development of a new immunotherapy for age-related diseases
Seeking funds to develop gene therapies that target ageing in humans and dogs
Potential oral treatment to prevent sarcopenia and frailty, and extend healthy lifespan
Raised $2.5 million to discover and sell life extension products directly to consumers
Eric Merle details Genoskin's technology and its applications in anti-ageing trials
Experimental therapy to transfuse healthy mitochondria from multiple donors
From drug discovery to longevity insights, a startup reshapes age-related medicine
A unique treatment approach for ageing; will soon begin trials in animals and human cadaver tissue
A rapamycin trial testing healthspan improvements in dogs; results may extrapolate to humans as well
Avoiding the spread of fake/misleading health information with ethical marketing
By investigating self-healing mechanisms in animals, Fauna bio aims to cure human diseases.
Novel gene therapies to prevent the accelerated aging process
Most approaches have their limitations but good progress is being made on several fronts
"Very promising" results from pilot study, with phase 3 clinical trial planned
Reverses immune ageing and can prevent death from coronavirus infection in the elderly
Working on its first two companies at the moment, aiming at global expansion in the coming years
Promotes healthy ageing with NR, and is safe and compatible with other supplements
Trials on mitochondrial transfusion might help tackle many ageing diseases
Supplement with science-based evidence on humans pioneering longevity industry
Instead of targeting specific hallmarks/pillars - they want to target ageing as a whole
Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soon
Patented compound on clinical trials to prove the benefits on human cognition
Funding targets early-stage companies and postdoc researchers with unique ideas
Novel approach with gold nanocatalyst technology to reverse neurodegenerative disease
Tracks your blood glucose in real time - helps optimise diet and exercise
Avenna's glyhealth alerts practitioners about subclinical chronic inflammation
Lead therapies of BioAge to treat age related diseases enter phase 2 trials
Keystone Bio's first ever biologic on the planet to eliminate oral pathogen
Nuchido's supplement boosts NAD+ four times higher than other products
Insights can tell what you should and shouldn't do to improve your longevity status
In 60 seconds, can identify ones rate of ageing, BMI, among others
Commercialization of tissue and organ regeneration process for clinical use
Old cells will be more young and beautiful
Maybe we need to develop senoplasts like resveratrol as well as senolytics
Whoever controls the shape of a molecule controls what it can do
Using AI to automatically read data from research paper databases and assess users for 20 diseases
Analysing IgG glycosylation: is it the most accurate measure of biological age?
After a successful phase 1 trial of the CVN424 done one mice, the company started phase 2 studies
Foundation of the new therapies mechanism is to access and control the compounds of CSF
Gray states biohacking is much beyond techniques and tests, rather more simple
UK residents can buy an AgeCurve sample kit and send a saliva sample